Загрузка...
Duration of intravenous antibiotic therapy in people with cystic fibrosis
BACKGROUND: Progressive lung damage from recurrent exacerbations is the major cause of mortality and morbidity in cystic fibrosis. Life expectancy of people with cystic fibrosis has increased dramatically in the last 40 years. One of the major reasons for this increase is the mounting use of antibio...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2019
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728060/ https://ncbi.nlm.nih.gov/pubmed/31487382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006682.pub6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|